Prof. Gershanik is currently Professor of Neurology at the Faculty of Medicine of the University of Buenos Aires. He also serves as Scientific Director and Head of the Unit of Abnormal Movements of the Institute of Neurosciences of the Favaloro Foundation. Until 2008 he was the Head of the Neurology Service of the French Hospital of Buenos Aires and Director of the Specialist Neurology Doctor of the University of Buenos Aires. In the field of basic research he develops his activities as Director of the Experimental Parkinson Laboratory of the Pharmacological Investigation Institute of the University of Buenos Aires and of the Council of Scientific and Technological Research (CONICET). Its clinical and basic research group was recognized by the National Parkinson Foundation (USA), which designated it for 10 years as a “Center of Excellence” in the field of assistance, research, teaching and outreach related to Parkinson.
Prof. Gershanik graduated with a Diploma of Honor at the Faculty of Medicine of the University of Buenos Aires in 1971. He completed his training in Neurology at the French Hospital, having been mentored by Prof. Alfredo F. Thomson. He received the title of Specialist Physician in Neurology in 1979, granted by the Ministry of Public Health of the Nation.
From 1978 to 1979 he was a Fellow in research at the Department of Neurology at Mount Sinai School of Medicine at the University of New York under the tutelage of Prof. Melvin D. Yahr, one of the pioneers in The field of research in Parkinson’s Disease. From 1981 to 1982 he returned to the United States, this time being invited as Associate Professor of Neurology and Neuropharmacology at the Department of Neurology at the University of New Jersey (Rutgers Medical School), under the direction of Prof. Roger C. Duvoisin, One of the precursors in the field of genetics of Parkinson’s Disease. On his return to Argentina he was appointed Head of the Extrapyramidal Diseases Section of the Neurology Service of the Hospital Francés de Buenos Aires, a position he held until he was appointed Head of the Neurology Service at that hospital in 2003. He held that position until the year 2008 in which he was appointed Scientific Director of the Institute of Neurosciences of the Favaloro Foundation. Both the Extrapyramidal Diseases Section and the Service under his direction were transformed into a pole of attraction for young neurologists, both from Argentina and from the region or from abroad who wanted to form under their tutelage in the field of Parkinson’s Disease and Abnormal Movements And in General Neurology. Numerous generations of successful neurologists in our country and abroad have been the result of this “school”.
The interests of Prof. Gershanik in the field of research have always been related to Parkinson’s Disease and Abnormal Movements, with special interest in subjects such as Parkinson’s Disease of early onset, sleep disorders in Parkinson’s Disease, Movements Abnormal drug-induced and Tourette’s Syndrome, to name a few. His contributions in the field of basic research have focused primarily on the pharmacology of dopaminergic receptors, interactions between dopaminergic receptor subtypes, and the role of different dopaminergic receptor subtypes in motor control in animal models of the disease Of Parkinson’s disease. Their investigations have contributed to dissipate the hypothesis of the in vivo toxicity of levodopa and in the present they are oriented to explore the expression of genes related to trophism and plasticity by dopaminergic drugs, the use of trophic factors to induce neuroprotection And / or neurorregeneration in animal models of Parkinson’s disease, and the analysis of the molecular mechanisms of levodopa-induced dyskinesias. He has published extensively on these subjects and is the most cited author in the field of Parkinson’s Disease and Abnormal Movements in Latin America.